Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CVS Health Corp
(NY:
CVS
)
78.47
+0.57 (+0.73%)
Official Closing Price
Updated: 7:00 PM EST, Nov 25, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CVS Health Corp
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
63
64
Next >
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
↗
September 11, 2024
UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amgen's Amjevita, in a move aimed at cutting prescription costs.
Via
Benzinga
CVS Shares Are Trading Lower Wednesday: What You Need To Know
↗
September 11, 2024
CVS Health Corporation (NYSE: CVS) shares are seeing a The sell-off comes in the wake of the recent Trump-Harris debate, which has created a wave of uncertainty in the healthcare sector. Here's what...
Via
Benzinga
Behind the Scenes of CVS Health's Latest Options Trends
↗
September 11, 2024
Via
Benzinga
Interest Rates, Private Equity, Stocks, Football...We've Got It All
↗
September 11, 2024
Including an interview with former NFL linebacker Brandon Copeland.
Via
The Motley Fool
Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies
↗
September 10, 2024
Baltimore secures an $80 million settlement with Teva Pharmaceuticals in its opioid crisis litigation. Funds will be allocated to education, recovery centers, and outreach initiatives.
Via
Benzinga
What 9 Analyst Ratings Have To Say About CVS Health
↗
September 10, 2024
Via
Benzinga
CVS Health's Options: A Look at What the Big Money is Thinking
↗
September 09, 2024
Via
Benzinga
CVS Investors Have Opportunity to Join CVS Health Corporation Fraud Investigation with the Schall Law Firm
September 10, 2024
From
The Schall Law Firm
Via
Business Wire
CVS Investors Have Opportunity to Lead CVS Health Corporation Securities Fraud Lawsuit With the Schall Law Firm
September 09, 2024
From
The Schall Law Firm
Via
Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CVS Health Corporation (CVS)
September 09, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
What the Options Market Tells Us About CVS Health
↗
September 05, 2024
Via
Benzinga
Peering Into CVS Health's Recent Short Interest
↗
September 04, 2024
Via
Benzinga
CVS DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages CVS Health Corporation Investors to Secure Counsel Before Important September 10 Deadline in Securities Class Action – CVS
September 09, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Rosen Law Firm Encourages CVS Health Corporation Investors to Secure Counsel Before Important September 10 Deadline in Securities Class Action with an Expanded Class Period– CVS
September 06, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
↗
September 06, 2024
Via
Benzinga
Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows
↗
September 06, 2024
These stocks offer above-average yields ranging between 2.8% and 5.1%.
Via
The Motley Fool
This Is What Whales Are Betting On CVS Health
↗
August 29, 2024
Via
Benzinga
CVS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Secure Counsel Before Important September 10 Deadline in Securities Class Action – CVS
September 05, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, Vicor, and American Airlines and Encourages Investors to Contact the Firm
September 03, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
↗
September 03, 2024
Via
Benzinga
Down About 65% in 2024, Is Walgreens Stock a Buy on the Dip?
↗
September 03, 2024
Shares of the dividend-paying pharmacy chain have been offering a double-digit yield percentage.
Via
The Motley Fool
CVS HEALTH CORPORATION (NYSE: CVS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds CVS Health Corporation Investors of Upcoming Deadline
September 03, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
2 Magnificent Stocks to Buy That Are Near 52-Week Lows
↗
September 02, 2024
These stocks have been dealing with some ire from investors.
Via
The Motley Fool
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm
August 30, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Patchy But Still Bullish
↗
September 02, 2024
Two weeks ago we turned to a more bullish stance, which has proved to be correct, though we still await the explosive movement out of these consolidations.
Via
Talk Markets
CVS Stock: Low Multiple, High Dividend. What Could Possibly Go Wrong?
↗
August 28, 2024
Chasing yield without conducting proper due diligence could be bad for your financial health.
Via
The Motley Fool
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm
August 26, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
CVS HEALTH CORPORATION (NYSE: CVS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds CVS Health Corporation Investors of Upcoming Deadline
August 26, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CVS
August 24, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
America's Future: Walgreens Versus Costco
↗
August 22, 2024
Via
Benzinga
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
63
64
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today